Medtech, whose major asset is New Zealand’s dominant GP and specialist patient management system, is up for sale, despite a depressed environment for software vendors.
Medtech, whose major asset is New Zealand’s dominant GP and specialist patient management system, is up for sale, despite a depressed environment for software vendors.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.